Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

MDM2 regulates estrogen receptor α and estrogen responsiveness in breast cancer cells.

Kim K, Burghardt R, Barhoumi R, Lee SO, Liu X, Safe S.

J Mol Endocrinol. 2011 Feb 15;46(2):67-79. doi: 10.1677/JME-10-0110. Print 2011 Apr.

2.

Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.

Saville B, Poukka H, Wormke M, Janne OA, Palvimo JJ, Stoner M, Samudio I, Safe S.

J Biol Chem. 2002 Jan 25;277(4):2485-97. Epub 2001 Nov 5.

3.

Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents.

Duong V, Boulle N, Daujat S, Chauvet J, Bonnet S, Neel H, Cavaillès V.

Cancer Res. 2007 Jun 1;67(11):5513-21.

4.

MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells.

Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y, Saji S, Hayashi S.

Biochem Biophys Res Commun. 2001 Feb 16;281(1):259-65.

PMID:
11178989
5.

Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.

Andruska N, Zheng X, Yang X, Helferich WG, Shapiro DJ.

Oncogene. 2015 Jul;34(29):3760-9. doi: 10.1038/onc.2014.292. Epub 2014 Sep 29.

6.

A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation.

Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J.

Breast Cancer Res. 2011 Jan 11;13(1):R3. doi: 10.1186/bcr2804. Erratum in: Breast Cancer Res. 2012;14(2):302.

9.

Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.

Zhang H, Xie X, Zhu X, Zhu J, Hao C, Lu Q, Ding L, Liu Y, Zhou L, Liu Y, Huang C, Wen C, Ye Q.

J Biol Chem. 2005 Dec 30;280(52):43188-97. Epub 2005 Oct 11.

10.

Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.

Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, Niki S, Murazawa C, Nakajima H, Kohno N, Yamashita H, Iwase H, Hayashi S, Ishida T, Yamauchi A.

Breast Cancer Res Treat. 2010 Jul;122(2):395-407. doi: 10.1007/s10549-009-0581-0. Epub 2009 Oct 22.

PMID:
19847644
11.

Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.

Gong EY, Park E, Lee K.

Cancer Sci. 2010 Sep;101(9):2019-25. doi: 10.1111/j.1349-7006.2010.01636.x.

12.

MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.

Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.

Oncogene. 2002 Jun 6;21(25):4000-8.

13.

Mechanisms of estrogen receptor antagonism toward p53 and its implications in breast cancer therapeutic response and stem cell regulation.

Konduri SD, Medisetty R, Liu W, Kaipparettu BA, Srivastava P, Brauch H, Fritz P, Swetzig WM, Gardner AE, Khan SA, Das GM.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15081-6. doi: 10.1073/pnas.1009575107. Epub 2010 Aug 9.

15.

Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.

Qiu J, Wang X, Guo X, Zhao C, Wu X, Zhang Y.

Oncol Rep. 2009 Oct;22(4):935-41.

PMID:
19724876
16.
17.

Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.

Kuske B, Naughton C, Moore K, Macleod KG, Miller WR, Clarke R, Langdon SP, Cameron DA.

Endocr Relat Cancer. 2006 Dec;13(4):1121-33.

18.

Decreased responsiveness of naturally occurring mutants of human estrogen receptor alpha to estrogens and antiestrogens.

Komagata S, Nakajima M, Tsuchiya Y, Katoh M, Kizu R, Kyo S, Yokoi T.

J Steroid Biochem Mol Biol. 2006 Jul;100(1-3):79-86. Epub 2006 May 18.

PMID:
16713253
19.

Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer.

Kim K, Barhoumi R, Burghardt R, Safe S.

Mol Endocrinol. 2005 Apr;19(4):843-54. Epub 2005 Jan 6.

PMID:
15637147

Supplemental Content

Support Center